$24.72
0.050.19%
At close: -
$25.40
0.682.76%
After Hours: Aug 5, 9:29 AM EDT
Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL)
Ticker | Name | Share % | |
---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | 5.76% | |
REGN | Regeneron Pharmaceuticals, Inc. | 5.45% | |
LLY | Eli Lilly & Co. | 4.91% | |
ALNY | Alnylam Pharmaceuticals Inc. | 4.85% | |
AS | Argenx Se Spon Adr Each Rep 1 Ord Shs | 4.77% | |
NBIX | Neurocrine Biosciences Inc | 4.54% | |
DNLI | Denali Therapeutics Inc | 4.18% | |
BIIB | Biogen Inc. | 3.94% | |
IL | Teva Pharmaceutical Industries Ltd Sponsored Adr | 3.81% | |
CRNX | Crinetics Pharmaceuticals Inc Com | 3.43% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
MNTL follows a Mid Cap Blend investment style.
The top holdings of MNTL include: VRTX (5.76%), REGN (5.45%), LLY (4.91%), ALNY (4.85%), AS (4.77%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for MNTL is currently not available.